CoChat

Effectiveness of a Medifast meal replacement program on weight, body composition and cardiometabolic risk factors in overweight and obese adults: a multicenter systematic retrospective chart review study

Open access

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Recent medical guidelines emphasize the importance of actively treating overweight and obesity with diet and lifestyle intervention to achieve ≥ 5% weight loss in a 6-month period. Commercial programs offer one approach provided there is evidence of their efficacy and safety. This study was conducted to evaluate the effectiveness of the Medifast® 4 & 2 & 1 Plan™ on weight loss, body composition and cardiometabolic risk factors in overweight and obese adults. METHODS: A systematic retrospective chart review of 310 overweight and obese clients following the Medifast 4 & 2 & 1 Plan at one of 21 Medifast Weight Control Centers® was conducted. Data were recorded electronically and key data points were independently verified. The primary endpoint was change from baseline body weight at 12 weeks. Within group paired t-tests were used to examine changes from baseline in a completers population. Differences between gender and age subgroups were examined using bivariate t-tests and mixed model regression analyses. RESULTS: For the primary endpoint at 12 weeks, body weight among completers (n = 185) was reduced by a mean of 10.9 ± 5.6 kg (-10.1%, p < 0.0001), and at 24 weeks (n = 81) mean weight was reduced by 16.0 ± 7.9 kg (-14.3%). At 12 and 24 weeks, 85% and 96% of those remaining on the plan, respectively, had lost ≥ 5% of their baseline body weight. Lean mass was preserved to within 5% of baseline throughout the 24 weeks, and fat mass represented ≥ 80% of the body weight lost from 12 weeks onward. Men, women, seniors (≥ 65 years), and non-seniors (<65 years) all had significant weight reductions with preservation of lean mass. Significant improvements in blood pressure, pulse and waist-to-hip ratio were observed. Mean weight regain among the subset who entered a formal maintenance phase was <2% during an average follow-up of 34 weeks. The meal plan was well tolerated, and program adherence was >85%. CONCLUSIONS: The 4 & 2 & 1 Plan used at Medifast Weight Control Centers was effective for weight loss, preservation of lean mass and improvement in cardiometabolic risk factors. The plan was generally well tolerated in a broad population of overweight and obese adults. #NCT02150837.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12937-015-0062-8

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Flow diagram. Chart disposition at week 12 (primary endpoint), week 24 and Final Visit. The Completers population included all individuals that had weight data within the specified visit window. Final Visit represents an individual’s last visit to the MWCC while following the 4 & 2 & 1 Plan. The time of the Final Visit varies by individual, depending on when they discontinued the 4 & 2 & 1 Plan
Fig. 1 Flow diagram. Chart disposition at week 12 (primary endpoint), week 24 and Final Visit. The Completers population included all individuals that had weight data within the specified visit window. Final Visit represents an individual’s last visit to the MWCC while following the 4 & 2 & 1 Plan. The time of the Final Visit varies by individual, depending on when they discontinued the 4 & 2 & 1 PlanCC BY · PubMed Central
Fig. 2 Percent change from baseline body weight. Mean (±SD) for the Completers population which included all individuals with weight data at the given visit; sample sizes are designated below the graph. Intention-to-Treat Last Observation Carried Forward (ITT LOCF) values are also shown for 12 and 24-week visits. Final Visit represents an individual’s last visit to the MWCC while on the 4 & 2 & 1 Plan. Absolute weight changes in kg are shown below the graph. Within group changes from baseline body weight using Wilcoxon signed-rank tests are shown: * p < 0.0001
Fig. 2 Percent change from baseline body weight. Mean (±SD) for the Completers population which included all individuals with weight data at the given visit; sample sizes are designated below the graph. Intention-to-Treat Last Observation Carried Forward (ITT LOCF) values are also shown for 12 and 24-week visits. Final Visit represents an individual’s last visit to the MWCC while on the 4 & 2 & 1 Plan. Absolute weight changes in kg are shown below the graph. Within group changes from baseline body weight using Wilcoxon signed-rank tests are shown: * p < 0.0001CC BY · PubMed Central
Fig. 3 Proportion of individuals with at least 5 % and at least 10 % reduction in baseline body weight. Analysis of the Completers population which included all individuals with weight data at the given visit; sample sizes are designated below the graph. Final Visit represents an individual’s last visit to the MWCC while on the 4 & 2 & 1 Plan
Fig. 3 Proportion of individuals with at least 5 % and at least 10 % reduction in baseline body weight. Analysis of the Completers population which included all individuals with weight data at the given visit; sample sizes are designated below the graph. Final Visit represents an individual’s last visit to the MWCC while on the 4 & 2 & 1 PlanCC BY · PubMed Central
Fig. 4 Change from baseline body weight, lean body mass and body fat mass. Mean (±SD) for the Completers population which included all individuals with weight data at the given visit; sample sizes are designated below the graph. Within group changes from baseline using Wilcoxon signed-rank tests are shown: * p < 0.0001
Fig. 4 Change from baseline body weight, lean body mass and body fat mass. Mean (±SD) for the Completers population which included all individuals with weight data at the given visit; sample sizes are designated below the graph. Within group changes from baseline using Wilcoxon signed-rank tests are shown: * p < 0.0001CC BY · PubMed Central
Fig. 5 Percent change from baseline in (a) body weight and (b) lean and fat mass by gender. Mean (±SD) for the Completers population which included all individuals with weight data at the given visit; sample sizes are designated below the graph. Final Visit represents an individual’s last visit to the MWCC while on the 4 & 2 & 1 Plan. Significance levels for all within group changes from baseline were p < 0.0001 for body weight and fat mass and p < 0.01 lean mass (not shown). Significance levels for between group comparisons using bivariate t-tests at each time point are shown: *p < 0.05; **p < 0.01; ***p < 0.0001
Fig. 5 Percent change from baseline in (a) body weight and (b) lean and fat mass by gender. Mean (±SD) for the Completers population which included all individuals with weight data at the given visit; sample sizes are designated below the graph. Final Visit represents an individual’s last visit to the MWCC while on the 4 & 2 & 1 Plan. Significance levels for all within group changes from baseline were p < 0.0001 for body weight and fat mass and p < 0.01 lean mass (not shown). Significance levels for between group comparisons using bivariate t-tests at each time point are shown: *p < 0.05; **p < 0.01; ***p < 0.0001CC BY · PubMed Central
Fig. 6 Percent change from baseline (a) body weight and (b) lean and fat mass by age group. Mean (±SD) for the Completers population grouped by age (<65 and ≥65 years). Completers included all individuals with weight data at the given visit; sample sizes are designated below the graph. Final Visit represents an individual’s last visit to the MWCC while on the 4 & 2 & 1 Plan. Significance levels for all within group changes from baseline were p < 0.0001 for body weight, p ≤ 0.002 for fat mass and p ≤ 0.05 for lean mass (not shown). Significance levels for between group comparisons using bivariate t-tests at each time point are shown: *p < 0.05; **p < 0.01; ***p < 0.0001
Fig. 6 Percent change from baseline (a) body weight and (b) lean and fat mass by age group. Mean (±SD) for the Completers population grouped by age (<65 and ≥65 years). Completers included all individuals with weight data at the given visit; sample sizes are designated below the graph. Final Visit represents an individual’s last visit to the MWCC while on the 4 & 2 & 1 Plan. Significance levels for all within group changes from baseline were p < 0.0001 for body weight, p ≤ 0.002 for fat mass and p ≤ 0.05 for lean mass (not shown). Significance levels for between group comparisons using bivariate t-tests at each time point are shown: *p < 0.05; **p < 0.01; ***p < 0.0001CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 55 references

Research works printed but not linked: 1

  1. Njeze GE. Gallstones. Nigeria: Nigerian Journal of Surgery; 2013.

Cited by

See all 34

Metadata

Authors
Coleman, C. D., Kiel, J. R., Mitola, A. H., Langford, J. S., Davis, K. N., & Arterburn, L. M.
Affiliations
Medifast, Inc. (United States) (US)
Corresponding author
Coleman, Christopher D.
Venue
Nutrition Journal
Published
2015-08-06
Volume
14
Issue
1
Pages
77-77
ISSN
1475-2891 (ISSN-L)
OpenAlex
W1922250856
Cited by
34
References
55
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 5 · 2022: 1 · 2020: 4 · 2019: 4 · 2018: 7 · 2017: 5 · 2016: 1 · 2015: 1
FWCI
3.44
Type
journal article
Language
en
Open access
Locations
  • Nutrition Journal (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
  • Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
Keywords
meal replacement, weight loss, obesity, overweight adults, body composition, lean mass preservation, fat loss, cardiometabolic risk factors, blood pressure, waist-to-hip ratio, weight regain, program adherence, commercial weight loss programs, weight maintenance, gender differences, age differences, older adults
MeSH terms
Adult, Aged, Body Composition, Body Weight, Cardiovascular Diseases, Diet, Diet, Reducing, Female, Follow-Up Studies, Humans, Life Style, Male, Middle Aged, Obesity, Retrospective Studies, Risk Factors, Body Mass Index, Metabolic Syndrome, Overweight, Meals

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effectiveness of a Medifast meal replacement program on weight, body composition and cardiometabolic risk factors in overweight and obese adults: a multicenter systematic retrospective chart review study. https://app.cochat.ai/papers/10.1186/s12937-015-0062-8
The paper
Coleman, C. D., Kiel, J. R., Mitola, A. H., Langford, J. S., Davis, K. N., & Arterburn, L. M. (2015). Effectiveness of a Medifast meal replacement program on weight, body composition and cardiometabolic risk factors in overweight and obese adults: a multicenter systematic retrospective chart review study. Nutrition Journal. https://doi.org/10.1186/s12937-015-0062-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.